Last reviewed: April 25, 2026 — Reviewed by: ZYNDIO Editorial Team

Tadalafil vs Sildenafil: Which PDE5 Inhibitor Is Right for You?

Sildenafil (Viagra) and tadalafil (Cialis) are both phosphodiesterase type 5 (PDE5) inhibitors and are the two most-prescribed medications for erectile dysfunction in the United States. They are not interchangeable. The molecules differ in onset, duration, sensitivity to food, dosing flexibility, and side effect profile in ways that make one a better fit than the other depending on the patient. This article walks through the comparison.

The shared mechanism

Both sildenafil and tadalafil inhibit phosphodiesterase type 5, the enzyme that breaks down cyclic guanosine monophosphate (cGMP) in penile vascular smooth muscle. By blocking cGMP breakdown, the medications enhance the natural vasodilatory response to sexual stimulation. Neither produces an erection without sexual stimulation; both amplify the body's normal response.

Both are FDA-approved for erectile dysfunction (sildenafil 1998, tadalafil 2003). Tadalafil is also approved for benign prostatic hyperplasia (BPH) at a daily dose, and the combination of tadalafil daily for BPH plus ED is one of the more elegant fits in this drug class.

Onset and duration

Sildenafil:

  • Onset: 30-60 minutes (faster on empty stomach).
  • Peak effect: ~1 hour.
  • Duration of clinically useful effect: ~4 hours.

Tadalafil:

  • Onset: 30-45 minutes.
  • Peak effect: ~2 hours.
  • Duration of clinically useful effect: 24-36 hours (the "weekend pill" reputation).

The duration difference is the dominant practical distinction. Tadalafil's long half-life (~17.5 hours) means a single dose maintains clinically useful PDE5 inhibition across an extended window — this is why many patients prefer tadalafil for spontaneity. Sildenafil's shorter window means timing is more relevant.

Food sensitivity

Sildenafil's absorption is meaningfully delayed and reduced by high-fat meals — patients are typically counseled to take it on an empty stomach or with a light meal for reliable onset.

Tadalafil's absorption is not significantly affected by food — patients can take it with any meal.

For patients whose ED is layered into a sit-down dinner setting, the food-insensitivity of tadalafil is often the deciding factor.

Daily-dose tadalafil

Tadalafil is FDA-approved at a low daily dose (2.5 mg or 5 mg) for ED in addition to the on-demand 10 mg or 20 mg dosing. Daily dosing eliminates the need to time medication around sexual activity and produces continuous PDE5 inhibition.

The daily-dose option is also the dose used for BPH (5 mg daily).

A separate article in this library covers daily tadalafil pros and cons in depth.

Side effects

The side effect profiles overlap substantially because both molecules act through the same enzyme target. Common side effects of both:

  • Headache
  • Flushing
  • Nasal congestion
  • Dyspepsia (heartburn / upset stomach)
  • Visual changes (blue-tinted vision more associated with sildenafil due to its weaker selectivity for PDE5 vs PDE6)
  • Back or muscle pain (more associated with tadalafil)

Serious side effects are rare and shared:

  • Priapism (erection lasting more than 4 hours) — urgent care indication.
  • Sudden hearing loss.
  • Non-arteritic anterior ischemic optic neuropathy (NAION).

Drug interactions

The most important interactions, shared:

  • Nitrates (nitroglycerin, isosorbide). Concurrent use is contraindicated — combination produces dangerous hypotension. This is the highest-priority interaction.
  • Alpha blockers (used for BPH or hypertension). Dose-staggering is generally required.
  • Strong CYP3A4 inhibitors (ketoconazole, ritonavir, certain antibiotics). Lower starting doses are warranted.

Who should not take PDE5 inhibitors

Standard contraindications:

  • Concurrent nitrate therapy.
  • Severe cardiovascular disease where sexual activity is unsafe.
  • Recent stroke or myocardial infarction.
  • Severe hepatic impairment.
  • Severe hypotension.

Patients with cardiovascular disease should have ED assessed in the context of overall cardiovascular fitness — ED can be an early marker of vascular disease, and the appropriate evaluation is medical workup rather than starting a PDE5 inhibitor and assuming the underlying condition is benign.

Choosing between them

Sildenafil tends to be the better choice when:

  • Cost is a primary factor (generic sildenafil is inexpensive).
  • The patient prefers a clear medication-on / medication-off window.
  • The patient does not have meals scheduled around intimacy.

Tadalafil tends to be the better choice when:

  • Spontaneity is a priority.
  • The patient also has BPH symptoms.
  • Meals around the timing of intimacy are common.
  • The patient prefers low-dose daily use.

There is no clinical superiority between the two molecules in terms of efficacy at appropriate doses for most patients. Comparative trials have generally shown both produce similar improvements in International Index of Erectile Function scores (Hellstrom et al., J Urol).

What about vardenafil and avanafil?

Vardenafil (Levitra) is a third PDE5 inhibitor with a profile similar to sildenafil.

Avanafil (Stendra) is a newer PDE5 inhibitor with faster onset (15-30 minutes) and a shorter half-life. It has lower visual side effects due to higher selectivity. It is more expensive and less widely prescribed.

For most patients, the practical choice is between sildenafil and tadalafil.

FAQ

Can I take sildenafil and tadalafil on different days? Not without clinician oversight. Stacking PDE5 inhibitors increases side effect risk without clear benefit, and tadalafil's long half-life means there is residual effect from the prior dose for 1-2 days.

Is the generic version as effective as Viagra or Cialis? FDA-approved generic sildenafil and tadalafil are bioequivalent to the branded products and are clinically equivalent at the FDA's approval standard.

Can I take a PDE5 inhibitor "just in case"? On-demand dosing is the standard use pattern. Daily dosing is a separate clinical decision.

Will it make me last longer? PDE5 inhibitors do not prolong ejaculatory latency. They affect the erectile component, not the ejaculatory component.

What if it does not work the first time? Approximately 30% of first-time users do not have a clinical response. The standard guidance is to try the medication 4-8 times under appropriate conditions before concluding it is ineffective. Dose adjustment may also help.

Medical Disclaimer: This content is educational and is not medical advice. Individual results vary. Off-label use should be discussed with your clinician. Compounded medications are prepared by FDA-registered compounding pharmacies but are not FDA-approved as a finished drug product.